What is the Evidence of Lymphoma in Patients with Prostheses Other Than Breast Implants?

• Published in: Aesthetic plastic surgery Vol. 44; no. 2; pp. 286 - 294
• Main Authors: Ramos-Gallardo, Guillermo, Carballo-Zarate, Adrián Alejandro, Cuenca-Pardo, Jesús, Cárdenas-Camarena, Lázaro, Solano-Genesta, Manuel, Beltrán, Jesús Aarón Curiel, Gallagher-Hernandez, Samantha, Contreras-Bulnes, Livia, Vélez-Benitez, Estela, Bucio-Duarte, José Javier, Cedillo-Alemán, Enrique Javier
• Format: Journal Article
• Language: English
• Published: New York Springer US 01-04-2020; Springer Nature B.V
• Subjects: Breast Implantation - adverse effects; Breast implants; Breast Implants - adverse effects; Cytokines; Humans; Lymphoma; Lymphoma, Large-Cell, Anaplastic - etiology; Medicine; Medicine & Public Health; Original Article; Otorhinolaryngology; Plastic Surgery; Prostheses; Quality of Life; Knee; Prostheses; Gluteus; Facial; Lymphoma non-Hodgkin; Lymphoma; Adverse effect; Hip; Dental
• ISSN: 0364-216X; 1432-5241
• DOI: 10.1007/s00266-019-01569-1

Introduction
Medical devices such as hip, knee, breast, vascular prostheses, among others, are very useful in different pathologies. We cannot doubt that their use is a great tool, besides being an advance in medicine; they provide a change in the quality of life of many patients; however, they are not exempt from adverse reactions and events.
Methods
We conduct a systematic review about lymphoma in the presences of prostheses other than breast implants.
Results
We selected 21 publications with a total of 24 patients. The largest number of prostheses was related to long bones in a total of 13 prostheses. The most frequent symptoms were: pain (52%), inflammation (24%), visible or palpable mass 20%. The most frequent type of lymphoma was non-Hodgkin B cell lymphoma in 14 cases.
Discussion
The presence of microparticles make biological degradation and wear of the implants, with macrophage and lymphocyte activation and the consequent production of proinflammatory cytokines such as tumor necrosis factor
α,
interleukin-1β, interleukin-6, and prostaglandin 2 (PGE2).
Conclusion
Lymphoma is not a common disease in patients with prostheses, and more data are needed to identify risk factors and make proper diagnoses.
Level of Evidence III
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors
www.springer.com/00266
.